Agios Pharmaceuticals, Inc.
MX ˙ BMV ˙ US00847X1046
SecurityMX:AGIO / Agios Pharmaceuticals, Inc.
InstitutionJacobs Levy Equity Management, Inc
Latest Disclosed Ownership28,530 shares
Latest Disclosed Value $ 965,170
Jacobs Levy Equity Management, Inc reports 74.33% decrease in ownership of AGIO / Agios Pharmaceuticals, Inc.

On May 15, 2026 - Jacobs Levy Equity Management, Inc filed a 13F-HR form disclosing ownership of 28,530 shares of Agios Pharmaceuticals, Inc. (MX:AGIO) valued at $965,170 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 111,150 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -74.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 28,530 -82,620 -74.33 965 -68.10 0.0041
2026-02-13 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 111,150 111,150 3,026 0.0117
2023-11-16 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -144,611 -100.00 0 -100.00
2023-08-14 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 144,611 -469,922 -76.47 4,095 -70.99 0.0236
2023-05-15 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 614,533 145,787 31.10 14,116 7.24 0.0865
2023-02-14 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 468,746 -17,980 -3.69 13,162 -4.38 0.0891
2022-11-15 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 486,726 89,711 22.60 13,765 56.38 0.1088
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 397,015 -68,837 -14.78 8,802 -35.09 0.0681
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 465,852 157,811 51.23 13,561 33.94 0.0912
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 308,041 5,494 1.82 10,125 -27.49 0.0678
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 302,547 84,525 38.77 13,963 16.21 0.0940
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 218,022 14,746 7.25 12,015 14.46 0.0814
2021-05-17 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 203,276 86,690 74.36 10,497 107.78 0.0810
2021-02-16 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 116,586 -19,701 -14.46 5,052 5.91 0.0443
2020-11-16 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 136,287 92,090 208.36 4,770 101.78 0.0494
2020-08-17 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 44,197 44,197 2,364 0.0256
2018-05-15 2018-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -15,500 -100.00 0 -100.00
2018-02-13 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 15,500 15,500 886 0.0156
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -78,537 -100.00 0 -100.00
2016-11-14 2016-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 78,537 45,347 136.63 4,148 198.42 0.0741
2016-08-15 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 33,190 33,190 1,390 0.0288
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.